|
|
NEW ON THE MARKET
|
|
Atomoxetine (STRATTERA) in attention deficit hyperactivity disorder (ADHD)
|
|
|
REVIEW
|
|
Biologicals efalizumab (RAPTIVA) and etanercept (ENBREL) in psoriasis
|
|
|
THERAPIES FROM A CRITICAL VIEWPOINT
|
|
TNT-study with atorvastatine (SORTIS): more is not better |
|
Clopidogrel (ISCOVER, PLAVIX) in acute myocardial infarction?
|
|
|
BEWARE MISINFORMATION
|
|
Withdrawal from the market of the cox-2 inhibitor valdecoxib (BEXTRA)
|
|
|
IN BRIEF
|
|
Value of proton pump inhibitors in bleeding peptic ulcer
Temozolomide (TEMODAL) in newly diagnosed glioblastoma
Psychostimulant pemolin (TRADON) off market in US as well
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Tinnitus with proton pump inhibitors - a group effect
|
|